Occasionally, patients with scleroderma also have or develop skeletal myopathies. Rheumatologist Julie Paik explains her recent study findings that these comorbidities lead to increase disease burdens and morbidity.
Director of Clinical Trials at the Johns Hopkins Myositis Center
Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California.